• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

猫传染性腹膜炎患猫的免疫介导性溶血性贫血

Immune-Mediated Hemolytic Anemia in Cats with Feline Infectious Peritonitis.

作者信息

Černá Petra, Knies Marieke, Assink Marleen, Evans Samantha, Tasker Séverine, Gunn-Moore Danièlle A, Hartmann Katrin, Buchta Katharina, Taylor Samantha, Meunier Solène, Hofmann-Lehmann Regina, Jacque Nicole, Koonce Allison, Jacobs Casandra, Gillett Ashley, Lappin Michael R

机构信息

Department of Clinical Sciences, Colorado State University, Fort Collins, CO 80523, USA.

Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, 3584 CT Utrecht, The Netherlands.

出版信息

Pathogens. 2025 Jul 4;14(7):660. doi: 10.3390/pathogens14070660.

DOI:10.3390/pathogens14070660
PMID:40732707
Abstract

Feline infectious peritonitis (FIP) is caused by mutated feline coronaviruses. Immune-mediated hemolytic anemia (IMHA) arises due to immune-mediated erythrocyte destruction and can be non-associative or associative with diseases such as FIP. Records of cats with FIP were reviewed to find those with associative IMHA based on exclusion of other causes of anemia and a positive saline agglutination test and/or Coombs test. The inclusion criteria were met for 45 cats (26 (58%) cats with effusive and 19 (42%) with non-effusive FIP). Median hematocrit was 18% (interquartile range [IQR] 13-20). Anemia was non-regenerative in 36 (80%) cats and regenerative in 5 (11%) cats; 4 (9%) cats had no reticulocyte count available. Concurrent thrombocytopenia was present in 18 (40%) cats. All 45 cats were treated with nucleoside analogs, and 44 (98%) cats with glucocorticoids; in 5 (11%) cats, glucocorticoids were added after starting antiviral treatment due to persistent anemia. Median follow-up was 72 days (IQR 14-246); at the time of last follow-up 33 (73%) cats had survived while 12 (27%) had died or were euthanized. Of the 33 surviving cats, 17 achieved remission of both FIP and IMHA. In three cats, FIP remission was achieved, but IMHA relapsed; in one of these, IMHA relapsed twice. FIP relapsed without IMHA in two cats, and both FIP and IMHA relapsed in one cat. In 9 cats the antiviral and glucocorticoid treatment is still ongoing at the time of the publication. Although FIP is likely an uncommon cause of associative IMHA, as more cats with FIP are treated with antiviral therapy, it is important to consider IMHA as a possible cause of anemia in cats with FIP.

摘要

猫传染性腹膜炎(FIP)由猫冠状病毒变异株引起。免疫介导的溶血性贫血(IMHA)是由于免疫介导的红细胞破坏所致,可与FIP等疾病无关或相关。回顾FIP猫的记录,以找出基于排除其他贫血原因以及盐水凝集试验和/或库姆斯试验呈阳性的相关IMHA猫。45只猫符合纳入标准(26只(58%)为渗出性FIP,19只(42%)为非渗出性FIP)。中位血细胞比容为18%(四分位间距[IQR]13 - 20)。36只(80%)猫的贫血为非再生性,5只(11%)猫为再生性;4只(9%)猫没有网织红细胞计数数据。18只(40%)猫同时存在血小板减少。所有45只猫均接受核苷类似物治疗,44只(98%)猫接受糖皮质激素治疗;5只(11%)猫因持续性贫血在开始抗病毒治疗后加用糖皮质激素。中位随访时间为72天(IQR 14 - 246);在最后一次随访时,33只(73%)猫存活,12只(27%)猫死亡或被安乐死。在33只存活的猫中,17只FIP和IMHA均缓解。3只猫FIP缓解,但IMHA复发;其中1只猫IMHA复发两次。2只猫FIP复发但无IMHA复发,1只猫FIP和IMHA均复发。9只猫在发表时抗病毒和糖皮质激素治疗仍在进行。虽然FIP可能是相关IMHA的罕见原因,但随着越来越多的FIP猫接受抗病毒治疗,将IMHA视为FIP猫贫血的可能原因很重要。

相似文献

1
Immune-Mediated Hemolytic Anemia in Cats with Feline Infectious Peritonitis.猫传染性腹膜炎患猫的免疫介导性溶血性贫血
Pathogens. 2025 Jul 4;14(7):660. doi: 10.3390/pathogens14070660.
2
Efficacy of oral remdesivir in treating feline infectious peritonitis: a prospective observational study of 29 cats.口服瑞德西韦治疗猫传染性腹膜炎的疗效:29只猫的前瞻性观察研究
J Feline Med Surg. 2025 May;27(5):1098612X251335189. doi: 10.1177/1098612X251335189. Epub 2025 May 27.
3
Short Treatment of 42 Days with Oral GS-441524 Results in Equal Efficacy as the Recommended 84-Day Treatment in Cats Suffering from Feline Infectious Peritonitis with Effusion-A Prospective Randomized Controlled Study.口服 GS-441524 治疗 42 天的疗效与推荐的 84 天治疗等效,用于治疗患有渗出性猫传染性腹膜炎的猫:一项前瞻性随机对照研究。
Viruses. 2024 Jul 16;16(7):1144. doi: 10.3390/v16071144.
4
Efficacy of GS-441524 for Feline Infectious Peritonitis: A Systematic Review (2018-2024).GS-441524治疗猫传染性腹膜炎的疗效:一项系统评价(2018 - 2024年)
Pathogens. 2025 Jul 19;14(7):717. doi: 10.3390/pathogens14070717.
5
Evaluation of the course of improvement with molnupiravir treatment for feline infectious peritonitis.莫努匹拉韦治疗猫传染性腹膜炎的改善过程评估。
Can Vet J. 2025 May;66(5):546-554.
6
A colloidal gold immunochromatographic test strip based on mAbs anti-N protein to detect feline coronavirus.一种基于抗N蛋白单克隆抗体的胶体金免疫层析试纸条,用于检测猫冠状病毒。
Microbiol Spectr. 2025 Jul;13(7):e0183024. doi: 10.1128/spectrum.01830-24. Epub 2025 Jun 2.
7
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
8
Comparative Genome Sequencing Analysis of Some Novel Feline Infectious Peritonitis Viruses Isolated from Some Feral Cats in Long Island.从长岛一些野猫中分离出的某些新型猫传染性腹膜炎病毒的比较基因组测序分析
Viruses. 2025 Jan 31;17(2):209. doi: 10.3390/v17020209.
9
Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer).纳武单抗用于成人霍奇金淋巴瘤(使用RobotReviewer软件进行的快速综述)
Cochrane Database Syst Rev. 2018 Jul 12;7(7):CD012556. doi: 10.1002/14651858.CD012556.pub2.
10
Pharmacokinetics of Molnupiravir in Cats with Naturally Occurring Feline Infectious Peritonitis.莫努匹拉韦在自然感染猫传染性腹膜炎的猫体内的药代动力学
Pathogens. 2025 Jul 7;14(7):666. doi: 10.3390/pathogens14070666.

本文引用的文献

1
Predictive factors associated with short-term mortality in cats with feline infectious peritonitis treated with remdesivir or GS-441524 or both.接受瑞德西韦或GS-441524或两者治疗的猫传染性腹膜炎猫短期死亡率的相关预测因素。
J Vet Intern Med. 2025 Jan-Feb;39(1):e17249. doi: 10.1111/jvim.17249. Epub 2024 Nov 27.
2
Open label clinical trial of orally administered molnupiravir as a first-line treatment for naturally occurring effusive feline infectious peritonitis.口服莫努匹韦作为一线治疗自然发生渗出性猫传染性腹膜炎的开放性标签临床试验。
J Vet Intern Med. 2024 Nov-Dec;38(6):3087-3094. doi: 10.1111/jvim.17187. Epub 2024 Sep 26.
3
Insights on feline infectious peritonitis risk factors and sampling strategies from polymerase chain reaction analysis of feline coronavirus in large-scale nationwide submissions.
从全国范围内大量送检样本的猫冠状病毒聚合酶链反应分析中获得的猫传染性腹膜炎风险因素及采样策略的见解
J Am Vet Med Assoc. 2024 Aug 30;263(1):82-89. doi: 10.2460/javma.24.03.0208. Print 2025 Jan 1.
4
Short Treatment of 42 Days with Oral GS-441524 Results in Equal Efficacy as the Recommended 84-Day Treatment in Cats Suffering from Feline Infectious Peritonitis with Effusion-A Prospective Randomized Controlled Study.口服 GS-441524 治疗 42 天的疗效与推荐的 84 天治疗等效,用于治疗患有渗出性猫传染性腹膜炎的猫:一项前瞻性随机对照研究。
Viruses. 2024 Jul 16;16(7):1144. doi: 10.3390/v16071144.
5
Myocarditis in an FIP-Diseased Cat with FCoV M1058L Mutation: Clinical and Pathological Changes.一只患有猫传染性腹膜炎(FIP)且携带猫冠状病毒(FCoV)M1058L突变的猫的心肌炎:临床和病理变化
Animals (Basel). 2024 Jun 3;14(11):1673. doi: 10.3390/ani14111673.
6
Serologic, Virologic and Pathologic Features of Cats with Naturally Occurring Feline Infectious Peritonitis Enrolled in Antiviral Clinical Trials.在抗病毒临床试验中纳入的自然感染猫传染性腹膜炎猫的血清学、病毒学和病理学特征。
Viruses. 2024 Mar 17;16(3):462. doi: 10.3390/v16030462.
7
Retrospective study and outcome of 307 cats with feline infectious peritonitis treated with legally sourced veterinary compounded preparations of remdesivir and GS-441524 (2020-2022).回顾性研究及合法兽医配制瑞德西韦和 GS-441524 制剂治疗 307 例猫传染性腹膜炎的结果(2020-2022 年)。
J Feline Med Surg. 2023 Sep;25(9):1098612X231194460. doi: 10.1177/1098612X231194460.
8
Clinical findings, treatment and outcome in cats diagnosed with precursor-targeted immune-mediated anaemia in a referral hospital in the UK: 30 cases (2010-2021).英国一家转诊医院诊断为前体靶向免疫介导性贫血的猫的临床发现、治疗及结果:30例病例(2010 - 2021年)
Vet Rec Open. 2023 Aug 27;10(2):e70. doi: 10.1002/vro2.70. eCollection 2023 Dec.
9
Molnupiravir treatment of 18 cats with feline infectious peritonitis: A case series.18 例猫传染性腹膜炎猫的莫努匹韦治疗:病例系列。
J Vet Intern Med. 2023 Sep-Oct;37(5):1876-1880. doi: 10.1111/jvim.16832. Epub 2023 Aug 8.
10
Outcomes of treatment of cats with feline infectious peritonitis using parenterally administered remdesivir, with or without transition to orally administered GS-441524.使用经肠胃外给予瑞德西韦治疗,以及是否转为经口给予 GS-441524 治疗猫传染性腹膜炎的效果。
J Vet Intern Med. 2023 Sep-Oct;37(5):1772-1783. doi: 10.1111/jvim.16803. Epub 2023 Jul 13.